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Material and Methods: Synthetic CT images (sCT) were generated using the Statistical Decomposition Algorithm (SDA, MriPlanner, Spectronic Medical AB, Sweden). The algorithm uses a T2-weighted MRI for sCT generation, based on a multi-template assisted classification method. In order to exclude the effect of geometrical distortions and patient deformation owing to reposition between imaging sessions, a registered CT (rCT) was constructed by deformable registration with the MR using the Elastix toolbox.
Five-field IMRT plans (both 6 and 10 MV) were created for six patients, using the Eclipse treatment planning system (Varian Medical Systems, Palo Alto, CA). Final dose calculations were made using the anisotropic analytical algorithm (AAA). The rCT was used for the initial treatment planning and the plan was recalculated on the sCT. Thus, the two treatment plans created for each patient had the same number of monitor units for each field. The resulting dose distributions from the rCT-and sCT-treatment plans were compared based on a set of dose volume histogram criteria according, and by using gamma evaluation. The reliability of the MRI-based fiducial marker identification was evaluated by an observer study. For this part of the study, the position of gold fiducial markers were determined by six independent observers using an MRI sequence dedicated for marker identification (LAVA-flex). Each marker position, three for each patient, were compared between the observers. The observers graded (one to five, were five represents the highest level of confidence) their confidence by which the markers for each patient were identified.
Results:
The mean dose differences to PTV between plans based on sCT and rCT were -0.1%±0.3% (1 s.d) (6MV) and -0.2%±0.2% (1 s.d) (10 MV). Gamma analysis showed pass rates ranging between 98% and 100% for both energies, with gamma criteria of 1%/2mm (local dose deviation). The mean standard deviation of the marker position, as determined by the observers, was 0.6 mm in all directions (x, y and z). One marker identification result was excluded due to an incorrect identification by one observer. The confidence grading ranged between 2 and 5.
Conclusion:
This work demonstrates that SDA can provide sufficient dosimetric accuracy for an MRI only workflow for prostate cancer patients. However, gold fiducials cannot be identified using LAVA-flex with high enough confidence and further work is needed to develop methods for marker identification in an MRI only workflow. Purpose or Objective: Prostate cancer patients scheduled for EBRT are often implanted with fiducial markers for position verification. A precondition for an MR-only workflow is the possibility to identify them on MRI. The markers present as signal voids in most images and their apparent position depends on their shape and orientation relative to the magnetic field. Rather than acquiring a sequence for this single purpose, we propose to use a model for the automatic detection of fiducial markers combining information from the entire multiparametric (mp) MRI protocol used for target delineation.
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Material and Methods:
Thirty prostate cancer patients scheduled for EBRT were implanted with 2-3 gold fiducial markers (0.9x3mm). A mp-MRI (T1w, T2w, B0-mapping and mDIXON) was performed using a 3T MRI (Achieva, Philips) and a CT with a 24-slice CT scanner (Somatom-Sensation-Open, Siemens).The reference position of the markers was based on the segmented CT images. The MRI was registered to the CT and resampled to the grid of 0.9x0.9x3mm3. A logistic regression model was developed to estimate the location of the markers based on the following MRI features: signal intensity, mean, median, min, max and standard deviation values in a kernel of 3x3x3vox and a multi-scale blobness filter [1] of the prostate region. The model was crossvalidated using a leave-one-out method. Performance was assessed using features from each separate imaging sequence and by combining the features from all sequences. Voxels detected as markers by the model were grouped into clusters. We defined the probability of each cluster candidate as the highest probability value of all voxels within it. Results were further post-processed by selecting the n(i) highest probability clusters, where n(i) is the number of markers implanted in patient i. Results were classified as a false positive (FP) if the distance between the reference centroid coordinates and the detected location was larger than 2.7mm in plane and 3mm in slice direction.
Results: Table1 shows the average AUC values for the model results of all patients using a single sequence and when combined. The combined model (AUC=0.94) performs significantly better than the best imaging sequence alone (T1-THRIVE AUC=0.84). Without post-processing the model correctly identifies 80/86 markers but with a total of 98 FP. After post-processing, we reduced the FP to a total of 20 but the true positives (TP) were also reduced to 66. Figure 1 shows the model pipeline. Deviations between the reference and the correctly identified marker location are < 1mm.
Conclusion:
The standard mp-MRI provides valuable information to detect fiducial markers. The combination of different sequences is more accurate than the use of a single sequence. The number of TP after processing needs to be further addressed but the overall findings support the feasibility of automatic marker detection in an MR-only workflow. 
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Purpose or Objective: Irregular breathing motion has a deleterious impact on thoracic and abdominal fourdimensional computed tomography (4DCT) image quality. Two pathways to overcome this problem are: (i) improving the regularity of breathing motion using the audiovisual biofeedback (AVB) breathing guidance system, and (ii) prospectively respiratory gating the 4DCT scan based on realtime respiratory motion. Until now, the effects of these technologies on 4DCT imaging have not been directly compared. The purpose of this study was to compare the impact of AVB and respiratory gating on thoracic 4DCT image quality and acquisition time using a deformable digital phantom driven by lung cancer patient breathing patterns
Material and Methods:
We obtained simultaneous measurements of chest, abdominal, diaphragm, and tumor motion for 6 lung cancer patients with tumor motion > 5 mm. Breathing signals were acquired under two breathing conditions: (1) AVB, and (2) free breathing. For each breathing condition, we used the 4D eXtended Cardiac Torso (XCAT) to simulate 4DCT acquisitions in the cine and respiratory gated mode. For each combination of breathing condition and acquisition mode, 4DCT image quality was quantified terms of Dice similarity coefficient between reconstructed and ground truth lung and tumor volumes (DSC(lung) and DSC(tumor), respectively), in addition to an automated method of artefact detection (utilizing normalized cross coefficient (NCC)). 4DCT acquisition times were also compared for each breathing condition and acquisition mode Results: In cine mode, AVB improved DSCl(ung) and DSC(tumor) by 0.3% (p = 0.005) and 0.3% (p < 0.001), respectively, and improved NCC by 11% (p = 0.002). In respiratory-gated mode, AVB did not have a significant impact on image quality. AVB increased the acquisition length of cine mode 4DCT by an average of 4 seconds, but reduced the length of respiratory gated acquisitions by 10 seconds. Respiratory gating improved image quality over cine mode irrespective of the breathing condition. Utilizing both AVB and respiratory gating together garners the greatest improvement in DSC(lung), DSC(tumor), and NCC values over conventional free breathing in cine mode by 0.9% (p < 0.001), 1.5% (p = 0.25), and 18.5% (p < 0.001), respectively Conclusion: This was the first study to directly compare the impact of breathing guidance and respiratory gating on 4DCT acquisition. We observed that AVB significantly improves the quality of 4DCT images in cine mode over free breathing, but can also reduce the amount of time needed to acquire a respiratory gated 4DCT scan. The results presented here demonstrate that AVB and respiratory-gating can both be beneficial pathways to improve 4DCT simulation for cancer radiation therapy, but the biggest gains are achieved when using these technologies simultaneously Purpose or Objective: The focus of this work is the development of a novel blade collimation system enabling volume-of-interest (VOI) CBCT using the kV source on a TrueBeam linear accelerator. Advantages of the system are assessed, particularly with regard to reduction and localization of dose, as well as improvement of image quality.
